2.50
Hdl Handle:
http://hdl.handle.net/10755/201797
Type:
Presentation
Title:
Screening Anxiety and Depression with COPD Patients
Abstract:
(41st Biennial Convention) Background Depressive symptoms are common among patients with chronic obstructive pulmonary disease (COPD). Anxiety and depression has been associated with poorer health outcomes. Depressive symptoms in patients with COPD are associated with poorer survival, persistent smoking, increased symptom burden, longer hospital stay, and poorer physical an social functioning. The lung department of the St Antonius Hospital has limited data available regarding the level of anxiety and depression with COPD patients during a hospital stay. Nurses could screen COPD patients during admission using the hospital anxiety and depression scale (HADS). But how big is the problem? Method The HADS is an easily administered, 14-item self-report measure comprising 7 anxiety items and 7 depression items from which separate anxiety and depression sub-scale scores are calculated. Patients were included in this baseline study, provided that they had been admitted with acute exacerbations of obstructive lung disease during April 2010. An acute exacerbation was defined as a change in condition for a COPD patient from baseline of such a magnitude that it needed an acute hospital admission. Patients with asthma were excluded. All patients were part of a COPD Clinical Pathway during there hospital stay. Results The HADS scores indicated presence of anxiety and depression. Fifty-one  patients completed the questionnaire.  For depression 20% (n = 10) had a probability score for depression (a depression scale score of >11) and could be seen by a psychiatrist for diagnose and treatment.   Conclusions The question whether patients admitted with a COPD exacerbation have an increased risk for depressive and /or anxiety have shown a highly relevant research question. Interventions that reduce depressive symptoms may potentially affect COPD outcomes. Screening for depression and anxiety is the first step. Nurses could play an important role by using the HADS for COPD patients at admission.
Keywords:
Bedside nursing research; Hospital Anxiety and Depression scales (HADS); COPD Clinical Pathway
Repository Posting Date:
11-Jan-2012
Date of Publication:
4-Jan-2012
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleScreening Anxiety and Depression with COPD Patientsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/201797-
dc.description.abstract(41st Biennial Convention) Background Depressive symptoms are common among patients with chronic obstructive pulmonary disease (COPD). Anxiety and depression has been associated with poorer health outcomes. Depressive symptoms in patients with COPD are associated with poorer survival, persistent smoking, increased symptom burden, longer hospital stay, and poorer physical an social functioning. The lung department of the St Antonius Hospital has limited data available regarding the level of anxiety and depression with COPD patients during a hospital stay. Nurses could screen COPD patients during admission using the hospital anxiety and depression scale (HADS). But how big is the problem? Method The HADS is an easily administered, 14-item self-report measure comprising 7 anxiety items and 7 depression items from which separate anxiety and depression sub-scale scores are calculated. Patients were included in this baseline study, provided that they had been admitted with acute exacerbations of obstructive lung disease during April 2010. An acute exacerbation was defined as a change in condition for a COPD patient from baseline of such a magnitude that it needed an acute hospital admission. Patients with asthma were excluded. All patients were part of a COPD Clinical Pathway during there hospital stay. Results The HADS scores indicated presence of anxiety and depression. Fifty-one  patients completed the questionnaire.  For depression 20% (n = 10) had a probability score for depression (a depression scale score of >11) and could be seen by a psychiatrist for diagnose and treatment.   Conclusions The question whether patients admitted with a COPD exacerbation have an increased risk for depressive and /or anxiety have shown a highly relevant research question. Interventions that reduce depressive symptoms may potentially affect COPD outcomes. Screening for depression and anxiety is the first step. Nurses could play an important role by using the HADS for COPD patients at admission.en_GB
dc.subjectBedside nursing researchen_GB
dc.subjectHospital Anxiety and Depression scales (HADS)en_GB
dc.subjectCOPD Clinical Pathwayen_GB
dc.date.available2012-01-11T10:53:22Z-
dc.date.issued2012-01-04en_GB
dc.date.accessioned2012-01-11T10:53:22Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.